Capillary blood tests measure p-tau217, GFAP, and NfL without strict temperature controls or immediate centrifugation. Primary care physicians currently have a diagnostic accuracy of ~61% for ...
A finger-prick blood test that can be mailed to a lab may offer a simpler way to detect the brain changes linked to Alzheimer’s disease, according to a new study. Researchers tested whether tiny ...
Alzheimer’s disease affects millions worldwide—but confirming a diagnosis is far from simple. Doctors currently rely on costly brain scans or invasive spinal fluid tests to identify the ...
Finger-prick test for Alzheimer's could actually change its diagnosis. An international research trial is exploring if a simple finger-prick blood test could one day help diagnose Alzheimer's disease ...
A simple finger-prick dried blood test accurately tracked Alzheimer’s-related brain changes in research settings, pointing to a future role in widening access to early screening while confirmatory ...
Finger-prick blood tests at home detected Alzheimer's biomarkers nearly as well as standard methods. The DROP-AD study suggested that dried blood spots could revolutionize screening approaches for ...
A simple finger-prick blood test could soon play a major role in diagnosing Alzheimer’s disease, according to researchers involved in a large international trial now under way. The study is examining ...
An international trial is examining whether a finger-prick blood test could be used to help diagnose Alzheimer's disease. The study, involving 1,000 volunteers aged over 60 in the UK, US and Canada, ...
THE DRIVER OF THE SCDOT TRUCK WAS TICKETED FOR SPEEDING. A NEW DEVELOPMENT IN ALZHEIMER’S AND DEMENTIA RESEARCH PAVES THE WAY FOR AN ACCESSIBLE AND LESS INVASIVE WAY TO DIAGNOSE DECLINING BRAIN ...
LONDON, Jan. 19, 2026 /PRNewswire/ -- A major international research project is underway to test whether a finger prick-style blood test could be used to help diagnose Alzheimer's disease. The trial ...
The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...